Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016–2019
Authors:
- Chi-Jung WuCWChi-Jung Wu
- Cong-Tat CiaCCCong-Tat Cia
- Hsuan-Chen WangHWHsuan-Chen Wang
- Chang-Wen ChenCCChang-Wen Chen
- Wei-Chieh LinWLWei-Chieh Lin
- Jen-Chieh LeeJLJen-Chieh Lee
- Po-Sheng ChenPCPo-Sheng Chen
- Chih-Cheng HsiehCHChih-Cheng Hsieh
- Wei-Ting LiWLWei-Ting Li
- Po-Lan SuPSPo-Lan Su
- Xin-Min LiaoXLXin-Min Liao
- Ming-I HsiehMHMing-I Hsieh
Open Access
- 4 January 2022
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 8 (1) , 49
Abstract
This study delineated the characteristics of 24 (11.2%) culture-positive, influenza-associated pulmonary aspergillosis (IAPA) patients out of 215 patients with severe influenza during 2016–2019 in a medical center in southern Taiwan. Twenty (83.3%) patients did not have EORTC/MSG-defined host factors. The mean time from influenza diagnosis to Aspergillus growth was 4.4 days, and 20 (83.3%) developed IAPA within seven days after influenza diagnosis. All patients were treated in intensive care units and all but one (95.8%) received mechanical ventilation. Aspergillus tracheobronchitis was evident in 6 (31.6%) of 19 patients undergoing bronchoscopy. Positive galactomannan testing of either serum or bronchoalveolar lavage was noted in all patients. On computed tomography imaging, IAPA was characterized by peribronchial infiltrates, multiple nodules, and cavities superimposed on ground-glass opacities. Pure Aspergillus growth without bacterial co-isolation in culture was found in 17 (70.8%) patients. A. fumigatus (15, 62.5%), A. flavus (6, 25.0%), and A. terreus (4, 16.7%) were the major causative species. Three patients had mixed Aspergillus infections due to two species, and two had mixed azole-susceptible and azole-resistant A. fumigatus infection. All patients received voriconazole with an all-cause mortality of 41.6%. Of 14 survivors, the mean duration of antifungal use was 40.5 days. In conclusion, IAPA is an early and rapidly deteriorating complication following influenza that necessitates clinical vigilance and prompt diagnostic workup.Keywords
Funding Information
- National Health Research Institutes, Taiwan (IV-107-PP-08, IV-108-PP-08, IV-109-PP-08.)
This publication has 27 references indexed in Scilit:
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2016
- Invasive Aspergillosis Associated With Severe Influenza InfectionsOpen Forum Infectious Diseases, 2016
- Different colonization patterns of Aspergillus terreus in patients with cystic fibrosisClinical Microbiology and Infection, 2014
- Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyIntensive Care Medicine, 2012
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2012
- High Resolution Genotyping of Clinical Aspergillus flavus Isolates from India Using MicrosatellitesPLOS ONE, 2011
- Azole Resistance Profile of Amino Acid Changes in Aspergillus fumigatus CYP51A Based on Protein Homology ModelingAntimicrobial Agents and Chemotherapy, 2010
- Aspergillus species identification in the clinical settingStudies in Mycology, 2007
- Intrapulmonary Penetration of Voriconazole in Patients Receiving an Oral Prophylactic RegimenAntimicrobial Agents and Chemotherapy, 2006
- Use of a Novel Panel of Nine Short Tandem Repeats for Exact and High-Resolution Fingerprinting of Aspergillus fumigatus IsolatesJournal of Clinical Microbiology, 2005